Marketing - Press Releases

Date	Title	Company
10-Aug-2020	Autolus Therapeutics Reports Second Quarter 2020 Financial Results and Operational Progress	Autolus Therapeutics plc
10-Aug-2020	OpenText enters agreement to serve as the platform of choice for enterprise information management for the U.S. National Institutes of Health	OpenText
10-Aug-2020	First-line immunotherapy combination, nivolumab plus ipilimumab, demonstrates significant improvement in overall survival vs. chemotherapy in unresectable malignant pleural mesothelioma patients in a phase 3 trial	Bristol Myers Squibb Company
10-Aug-2020	PTC Therapeutics Announces FDA Approval of Evrysdi™ (risdiplam) for the Treatment of Spinal Muscular Atrophy in Adults and Children 2 months and older	PTC Therapeutics, Inc
10-Aug-2020	The air cargo industry prepares for Covid-19 vaccine	The International Air Cargo Association (TIACA) and Pharma.Aero
10-Aug-2020	Significant clinical, financial and personnel milestones demonstrate strong value progression	Syncona Ltd
06-Aug-2020	Kantar Health Expands National Health and Wellness Survey into South Korea and Taiwan	Kantar
06-Aug-2020	PTC Therapeutics’ Mary Frances Harmon Named One of the Most Inspiring Leaders in Life Sciences by PharmaVOICE Magazine	PTC Therapeutics
04-Aug-2020	The new Marketplace for Pharma Business Opportunities is now online	Raucon
03-Aug-2020	Insilico Biotechnology AG reports progress on the use of methanol for the sustainable production of fine chemicals	Insilico Biotechnology AG
03-Aug-2020	UCL Technology Fund announces first close of £100m Fund 2	UCL Technology Fund
03-Aug-2020	Enterome scientists contribute to extensive new genomic and proteomic catalog to enhance analysis of the gut microbiome and understanding of its role in human health	ENTEROME SA,
03-Aug-2020	Novartis Cosentyx® receives EU approval for first-line systemic treatment in pediatric psoriasis	Novartis
03-Aug-2020	ASLAN PHARMACEUTICALS APPOINTS KENNETH KOBAYASHI, MD, AS CHIEF MEDICAL OFFICER	ASLAN Pharmaceuticals
03-Aug-2020	Lilly Initiates Phase 3 Trial of LY-CoV555 for Prevention of COVID-19 at Long-Term Care Facilities in Partnership with the National Institute of Allergy and Infectious Diseases (NIAID)	Eli Lilly
31-Jul-2020	CPhI Japan rescheduled for Spring 2021 with digital solutions to be launched	CPhI Japan
31-Jul-2020	Pharmapack Europe moves to May 2021	Pharmapack Europe
31-Jul-2020	Novadip Biosciences to Present at the LifeSci Partners Summer Symposium	Novadip Biosciences
31-Jul-2020	AMRYT TO HOST KEY OPINION LEADER CALL ON EPIDERMOLYSIS BULLOSA DISEASE LANDSCAPE	Amryt
31-Jul-2020	Enterome initiates first clinical trial with EO2401 – an innovative microbiome-antigen (‘OncoMimic’) based cancer immunotherapy candidate targeting aggressive brain cancer	Enterome